JBS (JBS)
NYSE:JBS
Top Page
JBS
(NYSE:JBS)
Select Model
Select Model
Rating:69Neutral
Price Target:
$19.00
▲(3.15% Upside)
Action:DowngradedDate:03/31/26
The score is driven primarily by improved operating results and strong revenue momentum, supported by attractive valuation (low P/E and high dividend yield). Offsetting factors are high leverage and weaker cash-flow conversion in 2025, while technicals are constructive but show signs of being near overextended.
Positive Factors
Diversified protein portfolio
JBS’s broad product mix across beef, poultry, pork and prepared foods plus monetization of by-products spreads revenue across categories and channels. This reduces single-commodity exposure, supports stable carcass economics, and sustains long-term cash generation despite cyclical swings in any one protein market.
Negative Factors
Elevated leverage
Substantial absolute debt and historically high leverage constrain financial flexibility and increase vulnerability to profit shocks. Even with improvement, high leverage limits ability to accelerate de-leveraging, raises interest costs in stress, and could force tougher trade-offs between debt reduction, capex and shareholder returns if margins deteriorate.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified protein portfolio
JBS’s broad product mix across beef, poultry, pork and prepared foods plus monetization of by-products spreads revenue across categories and channels. This reduces single-commodity exposure, supports stable carcass economics, and sustains long-term cash generation despite cyclical swings in any one protein market.
Read all positive factors
JBS (JBS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$19.68B
Dividend Yield9.72%
Average Volume (3M)4.99M
Price to Earnings (P/E)7.6
Beta (1Y)0.21
Revenue GrowthN/A
EPS Growth119.48%
CountryUS
Employees280,000
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.39
Shares Outstanding773,666,700
10 Day Avg. Volume5,187,285
30 Day Avg. Volume4,987,298
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.76
Price to Sales (P/S)0.18
P/FCF Ratio20.44
Enterprise Value/Market Cap15.44
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit4.86
Enterprise Value/Ebitda8.12
Forecast
1Y Price Target
$20.67Price Target Upside12.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.64
Revenue Forecast (FY)$90.86B
JBS Business Overview & Revenue Model
Company Description
JBS N.V., together with its subsidiaries, operates as a protein and food company worldwide. The company offers beef, pork, chicken, poultry, fish, and lamb products; cooked frozen meat; plant based products; and other food products. It also sells ...
How the Company Makes Money
JBS primarily makes money by processing livestock into branded and private-label food products and selling them through retail, foodservice, and wholesale/industrial channels, both in its home markets and via exports. Its core revenue stream comes...
JBS Earnings Call Summary
Earnings Call Date:Mar 25, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 19, 2026
Earnings Call Sentiment Positive
The call presented a predominantly positive operational and financial performance: record sales, solid adjusted EBITDA, strong returns (ROE 25%), improved liquidity and a conservative debt profile with long maturities. Regional highlights (Australia, Brazil) and brand momentum (Pilgrim’s Just Bare >$1B) underpin growth. However, near-term challenges remain material: U.S. beef supply tightness and volatility, working capital/deferred livestock timing effects, higher feed costs, and external trade/health and labor risks that can pressure margins and cash flow. On balance, the positives (record revenue, margin resilience, strong balance sheet and shareholder returns) outweigh the negatives, though risks warrant monitoring.Positive Updates
Record Revenue and Strong Full-Year Sales
Net sales reached a record $23.0 billion in Q4 and $86.0 billion for FY2025, representing company-record annual sales and 13% year-over-year growth for the year.
Negative Updates
U.S. Beef Supply Pressure and Volatility
U.S. cattle cycle remains under pressure with limited supply, high costs and significant volatility (negative spreads in Jan–Feb), and constrained processing volumes—conditions expected to continue and create margin swings.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Revenue and Strong Full-Year Sales
Net sales reached a record $23.0 billion in Q4 and $86.0 billion for FY2025, representing company-record annual sales and 13% year-over-year growth for the year.
Read all positive updates
Company Guidance
The company’s forward-looking guidance centered on 2026 planning assumptions and capital allocation: consolidated CapEx of $2.4 billion (≈$1.3B expansion, $1.1B maintenance), interest expense of $1.15B, lease expense of $500M and a consolidated effective tax rate of 25%; management said EBITDA cash‑flow breakeven would be about $5.7B if working‑capital/biologicals consumption matches 2025. Management reiterated a net‑debt/EBITDA target of 2–3x (current 2.39x), an average debt maturity of ~15 years and average debt cost of ~5.7% (≈90% fixed rate, no material maturities until 2031), with $4.8B cash and $3.5B of revolvers available; they also signaled a shareholder‑return policy targeting roughly $1/share (~$1B/year) in dividends while maintaining capital discipline (FY2025 IFRS adjusted EBITDA $6.8B / 7.9% margin, Q4 IFRS adj. EBITDA $1.7B, FY2025 FCF $400M, Q4 FCF $990M, net income $2.0B, EPS $1.89, ROE 25%, ROIC 17%).JBS Financial Statement Overview
Summary
Income Statement
71
Positive
Balance Sheet
55
Neutral
Cash Flow
46
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 471.14B | 416.95B | 363.82B | 383.97B | 362.50B |
| Gross Profit | 60.33B | 62.77B | 39.65B | 61.04B | 68.49B |
| EBITDA | 35.25B | 35.39B | 14.72B | 35.98B | 42.98B |
| Net Income | 11.10B | 9.62B | -1.06B | 15.85B | 21.24B |
Balance Sheet | |||||
| Total Assets | 248.34B | 251.94B | 206.13B | 208.11B | 207.25B |
| Cash, Cash Equivalents and Short-Term Investments | 25.98B | 34.76B | 22.12B | 13.18B | 23.24B |
| Total Debt | 125.71B | 134.93B | 110.33B | 104.41B | 103.61B |
| Total Liabilities | 195.97B | 201.57B | 159.13B | 158.30B | 159.45B |
| Stockholders Equity | 47.87B | 44.78B | 43.35B | 46.34B | 44.12B |
Cash Flow | |||||
| Free Cash Flow | 4.13B | 15.47B | 4.01B | 2.11B | 11.86B |
| Operating Cash Flow | 15.49B | 23.56B | 11.50B | 13.33B | 21.48B |
| Investing Cash Flow | -12.56B | -7.73B | -7.02B | -13.12B | -18.86B |
| Financing Cash Flow | -9.97B | -7.30B | 5.01B | -8.76B | -844.50M |
JBS Technical Analysis
Positive
18.42
Price Trends
16.17
Positive
15.28
Positive
14.71
Positive
Market Momentum
0.68
Negative
69.48
Neutral
90.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBS, the sentiment is Positive. The current price of 18.42 is above the 20-day moving average (MA) of 16.40, above the 50-day MA of 16.17, and above the 200-day MA of 14.71, indicating a bullish trend. The MACD of 0.68 indicates Negative momentum. The RSI at 69.48 is Neutral, neither overbought nor oversold. The STOCH value of 90.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBS.
JBS Risk Analysis
JBS disclosed 49 risk factors in its most recent earnings report. JBS reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
JBS Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $8.55B | 8.73 | 30.72% | ― | 1.81% | 24.67% | |
69 Neutral | $19.68B | 7.60 | 31.09% | 9.72% | ― | 119.48% | |
68 Neutral | $11.63B | 18.81 | 6.13% | 4.82% | 1.55% | -40.81% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $9.86B | -3.86 | -21.55% | 4.45% | -0.66% | -326.55% | |
54 Neutral | $27.55B | 11.00 | -13.44% | 6.75% | -3.70% | -431.05% |
* Consumer Defensive Sector Average
JBS
JBS
18.42
4.83
35.56%
HRL
Hormel Foods
21.13
-8.38
-28.40%
SJM
JM Smucker
92.47
-20.86
-18.41%
PPC
Pilgrim's Pride
35.99
-14.28
-28.41%
KHC
Kraft Heinz
23.27
-4.74
-16.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.